Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the cost of wholesale medications bought by the National Health Service.

The Department has well established mechanisms to control the level of spend on medicines. For example, the voluntary scheme for branded medicines pricing, access, and growth, the statutory scheme for branded medicines to control their growth in sales, and the National Institute for Health and Care Excellence’s evaluations all ensure that spend on new medicines represents a clinically and cost effective use of National Health Service resources.

The Government’s policy on generic medicines is to allow suppliers freedom of pricing for their products, relying on competition between suppliers and efficient purchasing by community pharmacies to deliver value for money for the NHS. However, this can mean that prices can fluctuate because of normal market forces, and can go up as well as down. Typically, this approach leads to some of the lowest prices of generic medicines in Europe.